A proof-of-concept study of direct magnetic resonance imaging-based proton dose calculation for brain tumors via neural networks with Monte Carlo-comparable accuracy
Muheng Li , Carla Winterhalter , Xia Li , Sairos Safai , Antony Lomax , Ye Zhang
{"title":"A proof-of-concept study of direct magnetic resonance imaging-based proton dose calculation for brain tumors via neural networks with Monte Carlo-comparable accuracy","authors":"Muheng Li , Carla Winterhalter , Xia Li , Sairos Safai , Antony Lomax , Ye Zhang","doi":"10.1016/j.phro.2025.100806","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and purpose</h3><div>Proton therapy currently relies on computed tomography (CT) imaging despite magnetic resonance imaging’s (MRI) superior soft-tissue contrast. While synthetic CTs can be generated from magnetic resonance (MR) images, this introduces additional complexity. We present a deep learning-based dose engine enabling direct proton dose calculation from MR images to streamline workflows while maintaining Monte Carlo (MC)-level accuracy.</div></div><div><h3>Materials and methods</h3><div>Using paired MR-CT scans from 39 brain tumor patients (29/3/7 for training/validation/testing), we developed a deep learning framework using various sequence models for individual proton pencil beam dose prediction. The framework processes beam-eye-view patches from 2000 random beam configurations per patient, varying in angles and energy, with corresponding MC dose distributions pre-calculated on CT. Models using CT images were trained for comparison.</div></div><div><h3>Results</h3><div>The xLSTM architecture performed best for both MR and CT-based scenarios among the evaluated sequence models. For full treatment plans, our model achieved gamma pass rates with median 99.8 % (range: 98.6 %–99.9 %, 1 mm/1%), and median percentage dose errors of 0.2 % (range: 0.1 %–0.4 %) within patient bodies and 1.3 % (range: 0.8 %–3.7 %) in high-dose regions (>90 % prescription dose). The model required only 3 ms per beam prediction compared to 2 s for MC simulation.</div></div><div><h3>Conclusion</h3><div>This study demonstrated the feasibility of MC-quality proton dose calculations directly from MR images for brain tumor patients, achieving comparable accuracy with faster computation and simplified implementation.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"35 ","pages":"Article 100806"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405631625001113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose
Proton therapy currently relies on computed tomography (CT) imaging despite magnetic resonance imaging’s (MRI) superior soft-tissue contrast. While synthetic CTs can be generated from magnetic resonance (MR) images, this introduces additional complexity. We present a deep learning-based dose engine enabling direct proton dose calculation from MR images to streamline workflows while maintaining Monte Carlo (MC)-level accuracy.
Materials and methods
Using paired MR-CT scans from 39 brain tumor patients (29/3/7 for training/validation/testing), we developed a deep learning framework using various sequence models for individual proton pencil beam dose prediction. The framework processes beam-eye-view patches from 2000 random beam configurations per patient, varying in angles and energy, with corresponding MC dose distributions pre-calculated on CT. Models using CT images were trained for comparison.
Results
The xLSTM architecture performed best for both MR and CT-based scenarios among the evaluated sequence models. For full treatment plans, our model achieved gamma pass rates with median 99.8 % (range: 98.6 %–99.9 %, 1 mm/1%), and median percentage dose errors of 0.2 % (range: 0.1 %–0.4 %) within patient bodies and 1.3 % (range: 0.8 %–3.7 %) in high-dose regions (>90 % prescription dose). The model required only 3 ms per beam prediction compared to 2 s for MC simulation.
Conclusion
This study demonstrated the feasibility of MC-quality proton dose calculations directly from MR images for brain tumor patients, achieving comparable accuracy with faster computation and simplified implementation.